REBEKAH GALLAUGHER: Open Payments
NPI 1093217408 · CHILLICOTHE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$369 in 25 payments from 9 companies in 2025. Trend: 2023 $822 · 2024 $702 · 2025 $369
Food & beverage: $359Education: $9
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $152 |
| Ardelyx, Inc. | 3 | $59 |
| Novo Nordisk Inc | 2 | $50 |
| Vifor Pharma, Inc. | 1 | $23 |
| SCPHARMACEUTICALS INC. | 1 | $21 |
| KYOWA KIRIN, INC. | 1 | $20 |
| Amgen Inc. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
| Travere Therapeutics, Inc. | 6 | $9 |
Products named: Kerendia, IBSRELA, Ozempic, Wegovy, Veltassa, FUROSCIX, CRYSVITA, TAVNEOS.
Industry payments across OH — which companies pay providers there.
